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ABSTRACT
Social prescribing is an approach that aims to improve
health and well-being. It connects individuals to non-
clinical services and supports that address social needs,
such as those related to loneliness, housing instability
and mental health. At the person level, social prescribing
can give individuals the knowledge, skills, motivation
and confidence to manage their own health and well-
being. At the society level, it can facilitate greater
collaboration across health, social, and community
sectors to promote integrated care and move beyond
the traditional biomedical model of health. While the
term social prescribing was first popularised in the UK,
this practice has become more prevalent and widely
publicised internationally over the last decade. This
paper aims to illuminate the ways social prescribing
has been conceptualised and implemented across 17
countries in Europe, Asia, Australia and North America. We
draw from the ‘Beyond the Building Blocks’ framework
to describe the essential inputs for adopting social
prescribing into policy and practice, related to service
delivery; social determinants and household production of
health; workforce; leadership and governance; financing,
community organisations and societal partnerships; health
technology; and information, learning and accountability.
Cross-cutting lessons can inform country and regional
efforts to tailor social prescribing models to best support
local needs.

SUMMARY BOX
⇒ Social prescribing is an approach that enables a

range of stakeholders, often based in healthcare, to
refer individuals to non-clinical interventions, such
as social activities and social services, to empower
individuals and improve their health and well-being.
⇒ Implementation of social prescribing is growing globally as a way to enable individual self-determination
and to address the social determinants of health.
⇒ The forms of adoption within countries reflect local
cultural, healthcare and political contexts.
⇒ More research and international coordination is
needed to most appropriately position social prescribing in healthcare and other societal systems
and to understand the impacts of this model and its
growth globally.

connections between SDH, health inequities
and health outcomes, as well as the role of
healthcare systems in addressing these SDH.2
Social prescribing aims to leverage health
and societal systems to address a range of
psychosocial factors in order to improve
health and well-being. It is a person-driven,
supported referral often between medical
and community assets. The model is rapidly
spreading around the world. In this paper, we
draw on examples from 17 countries (figure 1)
developing social prescribing programmes to
INTRODUCTION
Following the 2008 WHO Commission on the describe how it has been conceptualised and
Social Determinants of Health (SDH), global implemented around the world. We suggest
initiatives to address SDH focused on policy- what we consider to be its core components
level interventions, such as ‘Health in All’ and potential contributions to global SDH
approaches that engage actors across govern- action. This paper was informed by discusment, civil society, the private and research sions and iterative feedback with a working
sectors.1 Few global efforts have considered group of social prescribing practitioners,
the role of the health sector itself in mitigating researchers and advocates, convened through
adverse SDH and their downstream effects. the third International Social Prescribing
This is critical in the wake of the COVID-19 Conference hosted by the Social Prescribing
pandemic, which has demonstrated the Network.3 We also conducted interviews with
Morse DF, et al. BMJ Global Health 2022;7:e008524. doi:10.1136/bmjgh-2022-008524
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SOCIAL PRESCRIBING
As the global population ages and the burden of chronic
disease grows, the health and social sectors have considered additional and alternative approaches to improve
care delivery and health outcomes. While definitions vary
across and within countries, social prescribing involves a
deliberate, individualised process connecting individuals
to non-clinical services and activities, typically provided by
the voluntary and community sectors. Social prescribing
aims to improve individual health and well-
being,
support community capacity and self-
determination,
reduce health inequalities, optimise health service use
and decrease health service costs.4 5 The practice links to
multiple trends in global healthcare (box 1).
Social prescribing as it is now understood was developed
in the UK, with schemes dating back for decades. General
practitioners at the Bromley by Bow Health Partnership
launched a social prescribing scheme to refer patients
to in-house expert non-clinical services.6 Similar models
of service provision also existed in other countries, but
many were not united under the term social prescribing.
By 2016, the number of UK pilot schemes was growing,
prompting the creation of a new international Social
Prescribing Network3 and associated conference.7 At the
conference, a definition of social prescribing emerged:
the process of ‘enabling healthcare professionals to refer
patients to a link worker, to co-design a nonclinical social
prescription to improve their health and well-being’.7
In 2018, England implemented a national strategy to
reimburse one social prescribing ‘link worker’ for every
primary care network in the country, extending access
to more than 2.5 million individuals over 5 years. Since
then, advocates in the UK have worked to disseminate
their efforts through a ‘social prescribing day’, and more
broadly through a global network as part of the National
Academy of Social Prescribing, created by the National
Health Service (NHS) England and the Global Social
Prescribing Alliance, in partnership with the United
Nations.
As of 2021, social prescribing is gaining traction internationally with initiatives in at least 17 countries. Specific
components and implementation approaches vary across
settings, depending on country and community contexts.
In this paper, we use the ‘Beyond the Building Blocks’
framework8 (figure 2), which extends the WHO’s six
building blocks for health systems, to frame and describe
the key characteristics of social prescribing in these
varying contexts.
SERVICE DELIVERY
Social prescribing activities can vary in frequency, duration and degree of personalisation. Typically, a clinical
or non-clinical professional will refer people with unmet
social needs to a social prescribing worker, to identify
2

meaningful goals, co-create social prescriptions to relevant services, provide motivational support and even
co-attend activities. ‘Signposting’, the provision of general
resource lists or referral without ongoing follow-up, is
often noted as distinct from social prescribing because it
lacks the core components of person-centredness, integration and trackability.9 Some countries, however, use
the two terms interchangeably.
In terms of delivery, some healthcare-
based social
prescribing programmes opt for a broad approach and
make it available to all patients, as piloted in Portugal10
and Spain.11 Others target specific populations using
referral criteria based on medical conditions (eg,
diabetes, depression, anxiety, dementia),12–14 sociodemographic characteristics (eg, older adults, children and
adolescents, living in areas of high socioeconomic deprivation)14 15 or prior healthcare utilisation (eg, frequent
primary care or emergency department visits).16
Referrals from healthcare to social prescribing are,
most commonly, from primary care (Germany, Netherlands, England, Canada),5 17–19 but also come from outpatient services such as oncology and gynaecology (USA),20
community-
based nursing (Japan),21 mental health
teams (USA, UK),22 rehabilitation and intermediate care
(Singapore),23 and acute care or emergency departments
(USA, Australia).24
In some countries, identification is through standardised screening instruments for social risks such
as food insecurity or social isolation (Australia, USA,
Canada).20 There are also options for self-referral, or
referrals from non-healthcare professionals or community members such as hairdressers, taxi drivers or supermarket staff (Canada, England), but these approaches
are less common.25
SOCIAL DETERMINANTS AND HOUSEHOLD PRODUCTION OF
HEALTH
Underpinning social prescribing is health promotion,
defined by the WHO as ‘the process of enabling people
to increase control over, and to improve their health’.26
This transition from ‘what is the matter with you’ to
‘what matters to you’ entails a shift in understanding,
from being a resource supplied by providers to being,
at least in part, a product of individual and community
self-determination. Social prescribing includes components linked to self-determination, including autonomy
(the need to feel control over one’s life and decisions);
relatedness (the need to have close, affectionate relationships and to feel a sense of belonging); competence (the
ability to influence outcomes, be capable and effective);
and beneficence (the ability to give and to have a positive
impact on others).27
Whatever the context, prescribed social interventions
are inherently shaped by the target population and the
local landscape of services or activities available. These
can range from services that address basic material and
legal needs (eg, food, housing, transportation), lifestyle
Morse DF, et al. BMJ Global Health 2022;7:e008524. doi:10.1136/bmjgh-2022-008524
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and practice.
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interventions to improve health behaviours (eg, exercise, diet, smoking), programmes to develop professional
skills (eg, education, job training) or social activities (eg,
volunteering, arts and crafts, nature activities, community
engagement) (table 1).28 29 In the USA, social prescriptions have largely focused on connecting patients to
resources for basic needs, given significant socioeconomic inequalities and a weaker public social safety net.30
In Sweden,31 the Netherlands18 and countries that position social prescribing as part of larger Healthy Aging
national strategies, such as Singapore and China, social
prescriptions have often focused on social isolation and
overall well-being.23 32
The WHO estimates 70%–90% of healthcare takes
place in the home.8 Thus, social prescribing efforts
have increasingly focused on the household production of health—the role of broader family or household
members in shaping an individual’s health behaviours
and disease management. Social prescribing contributes
through a range of mechanisms such as reducing the
burden on carers; developing daily routines of eating and
socialising; and impacting the health of household and
neighbourhood environments.
WORKFORCE
Implementing social prescribing requires a workforce
to assess individual needs and facilitate linkages to non-
clinical supports. Across countries, titles for new social
prescribing roles have been tailored to resonate with
the local culture and population: ‘link worker team’
in China,32 ‘well-
being coordinator’ in Singapore,23
‘community connector’ in Wales33 and ‘well-
being
coach’ in the Netherlands.18 While customising workforce titles may facilitate stakeholder buy-in for local
Morse DF, et al. BMJ Global Health 2022;7:e008524. doi:10.1136/bmjgh-2022-008524

adoption, lack of standardisation can make international and national comparisons of social prescribing
workforce difficult.34
Some countries have repurposed existing healthcare
staff to administer social prescriptions. The first social
prescribing projects in Portugal,10 Germany,19 Japan21
and Canada35 added these responsibilities to the roles
of social workers, allied health professionals, nurses and
volunteers. In Spain, social prescriptions are provided
directly by primary care physicians, whose ongoing relationships with patients enable them to co-produce appropriately tailored prescriptions.11 Health systems in the
USA often use existing clinical and non-
clinical staff,
while also developing and training new roles specifically
for social prescribing.20
There is the potential to employ social prescribing
roles outside healthcare, for example, in community
and social services as in Wales and the Netherlands.18 33
Programme evaluation metrics will likely be influenced
by those common in the sector in which the worker is
employed.36
While there is currently no professional registration
for social prescribing workers, England, Wales and the
Netherlands have made progress in developing competency frameworks and training curricula. Competencies
include partnership working, confidentiality, impact
measurement, active listening, motivating and solution-
based skills, and understanding the wider determinants
of health and well-being.33 36 English link workers created
a professional membership body, the National Association of Link Workers, to promote professional development and create opportunities to share learning.37 Dutch
well-being coaches are social workers additionally trained
in Welzijn op Recept through a collaboration of the
3
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Figure 1 Examples of 17 countries which have developed and/or implemented social prescribing programmes: China, South
Korea, Germany, Denmark, Australia, Finland, Sweden, Spain, Singapore, Ireland, the Netherlands, Portugal, Canada, New
Zealand, UK, USA and Japan.
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⇒ Person-centred care: eliciting individuals’ values and preferences

⇒

⇒
⇒

⇒

⇒

⇒

⇒

⇒

⇒

to guide all aspects of their care and to support their realistic health
and life goals.70
Integrated care: promoting comprehensive delivery of person-
centred services across the life-course, designed to meet the multidimensional needs of individuals and delivered by a coordinated
multidisciplinary team of staff working across settings and levels
of care.71
Co-design: involving service users in the service design process
and working with them to understand their met and unmet needs.72
Co-production: working with individuals who use health and care
services, carers and communities in equal partnership, and working with groups of people at the earliest stages of service design,
development and evaluation.73
Self-determination theory: recognising that individuals who experience self-determination (ie, the ability to make choices and exert
control over one’s life) are more motivated to take action and experience greater psychological health and well-being.27
Care coordination: deliberately organising health and social care
activities, and sharing information among all participants involved
with an individual’s care to achieve safer and more effective care.74
Health promotion: enabling people to increase control over and
to improve their health, and moving beyond a focus on individual behaviour towards a wide range of social and environmental
interventions.75
Strengths-based approach: collaborating between the person supported by services and those supporting them and allowing them to
work together to determine an outcome that draws on the person’s
strengths and assets.76
Asset-
based community development: recognising that people
in communities can organise to drive the development process
themselves by identifying and mobilising existing (but often unrecognised) assets.77
Quadruple aim: enhancing patient experience, improving population health, reducing costs and improving the work life of healthcare clinicians and staff.78

social workers union and the National Welzijn op Recept
network in the Netherlands.38
More broadly, all aligned roles should be offered
training and support. Raising awareness of social
prescribing roles is important to increase system buy-in
and understanding of what constitutes a ‘good’ referral.
In the UK (and more recently in other countries like
Australia, Portugal and the USA), social prescribing
‘champion’ programmes that engage with trainees and
students have aimed to improve staff buy-in.39 Relatedly,
supervision of social prescribing staff is important, given
they are often working with vulnerable individuals experiencing difficult life circumstances.
LEADERSHIP AND GOVERNANCE
In the UK, grassroots organising and early pilots influenced robust national-level implementation.7 Our practitioner experts reported in our interviews that leaders
in the UK and elsewhere sought governmental support,
aligning with existing structures (eg, Wellness Centres
4

in the Netherlands) and priorities (eg, the Healthy
China Action Plan, Singapore National Action Plan for
Successful Ageing and English policies related to loneliness).40–42 In Australia, leadership has been provided
by both local community health centre pilots (ICP
Health) and a comprehensive national policy collaboration between healthcare users and providers—the
Consumers Health Forum and the Royal Australian
College of General Practitioners.43 In Canada, tracking
health improvements and service cost reduction was
essential to convince stakeholders to invest in social
prescribing.35 The triad of locally tested implementation
pilots, supportive stakeholders and robust government
support is emerging as an important combination for
social prescribing’s success at the national scale.
International implementers and practitioners in turn
have begun to share promising practices through the
English-based Social Prescribing Network3 and its global
spinoff, the International Social Prescribing Network.
Policy actors involved with global governance have also
begun to amplify impact through the WHO and United
Nations-linked Global Social Prescribing Alliance.

FINANCING, COMMUNITY ORGANISATIONS AND SOCIETAL
PARTNERSHIPS
Financing approaches for social prescribing approaches
vary across countries.44 Existing studies and our interview
data showed that implementation of social prescribing
may not require new funds if health systems are able to
repurpose existing staff and infrastructure (Portugal,
Canada, Netherlands, Spain, Japan).10 18 21 However,
many programmes do require additional funding, for
salaries, management and infrastructure.45 This can be
developed from existing routes such as research funding
(Korea),14 or more flexible health funding mechanisms
(value-based payments in the USA).46 In England and
Australia, funds have been granted through explicit
additional mechanisms (NHS England reimbursement
in primary care networks and Australia’s Primary Health
Networks).47 48
The coordination of health systems, governments and
community-
based organisations delivering activities is
centrally important.34 Otherwise, there is a risk of underfunding and overprescribing community services. The
Danish government, for instance, financially supported
‘Exercise by Prescription’ as a nationwide concept.
However, there was no link worker to follow up with
patients, and the exercise programmes offered by the
physiotherapists were too generic and did not take into
account the needs of different individuals.49 In a pilot
in Lisbon, Portugal, this coordination risk was mitigated
through regularly integrating stakeholder input.10 North
Carolina, USA will extend this collaborative approach
by directly reimbursing community-
based organisations that receive referrals from the health sector.50 In
Wales, funding decisions have been devolved to regional
Morse DF, et al. BMJ Global Health 2022;7:e008524. doi:10.1136/bmjgh-2022-008524
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BOX 1 TRENDS IN GLOBAL HEALTHCARE THAT HAVE
INFORMED SOCIAL PRESCRIBING
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partnership boards that include representatives from the
health, social, voluntary and housing sectors.51
HEALTH TECHNOLOGY
Technology has been used at all stages of the social
prescribing referral pathway. First, electronic medical
records can be helpful in the identification of potential referrals, through patterns of healthcare use, other
screening tools, or employing algorithms and artificial
intelligence to predict social needs.52 Second, technology
can support asset mapping. Digital maps and databases of
referrable community resources (Spain, Australia, USA,
Canada, Wales) can aid understanding of what resources
currently exist in local communities.53 Mobile apps for
sharing referrals and care plans (Singapore) help bridge
technological divides across sectors and providers. Integrated platforms for cross-
sector communication and
referral (UK, USA, Canada) facilitate resource curation
Table 1 Examples of social prescriptions across
dimensions of health
Material needs

Health
behaviours

Social–emotional

Food
Transportation

Diet
Exercise

Social relationships
Nature exposure

Financial needs

Smoking

Arts and cultural
activities

Legal needs

Substance use

Volunteering

Housing

Chronic disease
management
Mental health
counselling

Job training and
education
Community groups

Digital inclusion

Morse DF, et al. BMJ Global Health 2022;7:e008524. doi:10.1136/bmjgh-2022-008524

and referrals.54 Third, process tracking technologies can
support evaluation and quality improvement. Process
measures can assess if a referral takes place (enrolment), if it is taken up (engagement) and if an activity
is completed (adherence).55 Outcome measures, while
diverse and include individual, community and system
impacts, can often be captured through health technologies.
As with any technological solution, there are challenges across all contexts. Available community services
change over time, staff may require training on platforms
used and working across organisations presents further
challenges. There have been efforts to standardise data
coding (UK, USA), and to compile data across services.56
Standardised data, such as England’s Social Prescribing
Observatory, enable comparisons across programmes
and demonstrate the diverse needs of communities as
well as areas for further SDH interventions. The development of agreed standardised indicators for social
prescribing would facilitate global knowledge exchange
and mobilisation.

INFORMATION, LEARNING AND ACCOUNTABILITY
Evidence related to social prescribing is still emerging.
Studies demonstrate the potential for positive health
benefits, including improved self-reported well-being, and
reduced loneliness28 57 or healthcare demand.58 There is
growing evidence for the various activities undertaken
(physical activity, healthy eating, volunteering,59 time in
nature,60 engagement with the arts61), with randomised
controlled trials and strong quasi-experimental studies
completed or underway to understand effectiveness of
social prescribing schemes.30 62–64 Additionally, reviews
5
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Figure 2 ‘Beyond the Building Blocks’ expanded framework from Sacks et al8. CHV, community health volunteer; CHW,
community health worker.
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CONCLUSION
Social prescribing shows promise for delivering healthcare action on SDH, and potentially impacting individual and community health through a person-centred,
supported referral pathway. Drawing on examples from
17 countries around the globe, the Beyond the Building
Blocks framework demonstrates some of the key characteristics and contributions of social prescribing to diverse
health systems. In summary:
► Service delivery and household/social determinants
of health: social prescribing moves care upstream
determination and
to address SDH through self-
supported referral to community, voluntary and
social services. Countries need to prioritise which
populations to focus efforts towards (eg, older adults,
persons with long-
term medical conditions, etc)
and from which settings they should engage staff to
initiate referrals (eg, primary care, community-based
organisations, etc).
► Health workforce: social prescribing requires a new
or existing workforce of paid staff or volunteers
to support individuals and communities through
co-designed referrals. Training curricula and competency frameworks are needed to ensure that social
prescribing providers have the knowledge and skills
to be responsive to the complex needs of a diverse
range of individuals.
► Financing, community organisations and societal partnerships: the health sector currently leads financing
approaches, with social care financing models slower
to emerge. Countries must explore which financing
mechanisms can best support their programmes
and align with existing initiatives, depending on
their stage of adoption and need for flexibility (eg,
leveraging existing staff and resources, applying for
research funds or advocating for new government
investments). Special attention must also be given
to support the voluntary sector organisations that
6

receive referrals, and not just the social prescribing
programme itself.
► Leadership and governance: leaders working to start
social prescribing programmes in their country have
gained initial traction through grassroots implementation and pilots, policy-first approaches or a combination of both. Countries considering adopting social
prescribing approaches should consider joining one
of the cross-national leadership networks devoted to
developing the field (eg, Global Social Prescribing
Alliance, International Social Prescribing Network).
► Health technology: technology can support social
prescribing across the referral pathway, from identifying individuals who might benefit from social
prescribing, to aggregating available referrals through
centralised resource directories, to tracking process
and outcome measures. Countries should consider
how standardised data coding and shared technology
platforms can optimise service delivery and facilitate
cross-sector collaboration.
► Information, learning and accountability: there is a
need for a nuanced evidence base to assess implementation, effectiveness, cost-effectiveness and impact on
health inequalities across diverse populations and
geographies. Each country must decide which measures of success are most important to them, how
they define return on investment and how to engage
researchers in supporting evaluation to inform future
efforts.
Overall, our practice experience in 17 countries shows
that social prescribing has the potential to contribute to
global goals for health and well-being, including United
Nations targets (Sustainable Development Goal 3: Good
Health and Well-Being), through reductions in health
services use, empowerment, stronger intersectoral partnerships and improved measurability of SDH interventions. Global, collaborative efforts are needed to support
robust evaluations in order to grow the evidence base
and understand what works, in which contexts and for
whom. As the world grapples with the inequitable fallout
from the COVID-19 pandemic, the imperative for healthcare and social sector action on SDH is clear.
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